Ad is loading...
FRDAX
Price
$100.91
Change
+$0.49 (+0.49%)
Updated
Nov 22 closing price
VSTSX
Price
$284.30
Change
+$1.52 (+0.54%)
Updated
Nov 22 closing price
Ad is loading...

FRDAX vs VSTSX

Header iconFRDAX vs VSTSX Comparison
Open Charts FRDAX vs VSTSXBanner chart's image
Franklin Rising Dividends Adv
Price$100.91
Change+$0.49 (+0.49%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$284.30
Change+$1.52 (+0.54%)
VolumeN/A
CapitalizationN/A
FRDAX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRDAX vs. VSTSX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRDAX is a StrongBuy and VSTSX is a StrongSell.

FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.73T vs. FRDAX (28.7B). VSTSX pays higher dividends than FRDAX: VSTSX (1.36) vs FRDAX (1.11). FRDAX was incepted earlier than VSTSX: FRDAX (19 years) vs VSTSX (8 years). VSTSX is a more actively managed with annual turnover of: 2.00 vs. FRDAX (1.88). FRDAX has a lower initial minimum investment than VSTSX: FRDAX (100000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 31.91 vs. FRDAX (15.69). VSTSX return over 5 years is better than : 88.30 vs. FRDAX (51.74).
FRDAXVSTSXFRDAX / VSTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years8 years-
Gain YTD15.24525.12361%
Front LoadN/AN/A-
Min. Initial Investment10000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets28.7B1.73T2%
Annual Yield % from dividends1.111.3682%
Returns for 1 year15.6931.9149%
Returns for 3 years4.4723.8019%
Returns for 5 years51.7488.3059%
Returns for 10 years100.46N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NIO4.840.14
+2.98%
NIO Inc.
TRX0.360.01
+1.72%
TRX Gold Corp
ARWR18.540.26
+1.42%
Arrowhead Pharmaceuticals
TOVX1.28N/A
N/A
Theriva Biologics Inc
CDXC7.44-0.19
-2.49%
ChromaDex Corp